, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

down 63.18 %

Ariad Pharmaceuticals, Inc. (ARIA) rated Outperform by William Blair

Posted on: Monday,  Jul 30, 2012  2:25 PM ET by William Blair

William Blair rated Outperform Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 07/30/2012, when the stock price was $18.96. Since
then, Ariad Pharmaceuticals, Inc. has lost 63.19% as of 01/19/2016's recent price of $6.98.
If you would have followed this William Blair's recommendation on ARIA, you would have lost 63.18% of your investment in 1268 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/30/2012 2:25 PM Buy
as of 12/31/2012
1 Week down  -5.84 %
1 Month down  -14.22 %
3 Months down  -20.77 %
1 YTD up  1.16 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy